Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Structure and Function of Platelets01:18

Structure and Function of Platelets

3.7K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.7K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1000
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1000
Types of Functions I01:26

Types of Functions I

316
Functions are fundamental mathematical tools that capture relationships between variables and describe how one quantity changes in relation to another. Their diverse forms allow them to model various real-world phenomena with precision and flexibility. Among the various categories, algebraic functions are prominent due to their formulation through basic arithmetic operations: addition, subtraction, multiplication, division, and root extraction.Algebraic functions include polynomial, rational,...
316
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Types of Functions II01:19

Types of Functions II

205
Trigonometric and exponential functions are essential mathematical tools used to model distinct types of real-world behavior, particularly in periodic and growth-related phenomena. These functions extend the capabilities of basic algebraic models by capturing recurring cycles and rapid changes across various scientific and engineering contexts.Trigonometric functions, such as sine and cosine, are particularly effective for representing periodic phenomena. Their cyclic behavior makes them...
205

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ADA-HF: acetazolamide as a chloride sparing diuretic in patients admitted to hospital with heart failure.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

Diagnosis of metaphyseal fractures in infants and young children with suspected inflicted injury: a systematic review of cross-sectional imaging techniques.

Clinical radiology·2023
Same author

Non-invasive assessment of fecal glucocorticoid, progesterone, and androgen metabolites and microbiome in free-ranging southern white rhinoceros (Ceratotherium simum simum) in South Africa.

General and comparative endocrinology·2022
Same author

Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?

European heart journal. Quality of care & clinical outcomes·2022
Same author

Antiplatelet therapies in diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Physiologically relevant screening of polyphenol-rich commercial preparations for bioactivity in vascular endothelial cells and application to healthy volunteers: A viable workflow and a cautionary tale.

Biochemical pharmacology·2019

Related Experiment Video

Updated: Feb 10, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

1.1K

Platelet function following induced hypoglycaemia in type 2 diabetes.

H Kahal1, A Aburima2, B Spurgeon2

  • 1Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK; Centre for Cardiovascular and Metabolic Research, Hull York Medical School, Hull, UK.

Diabetes & Metabolism
|May 23, 2018
PubMed
Summary

Hypoglycaemia in type 2 diabetes (T2DM) impairs platelet function by reducing prostacyclin sensitivity. This platelet hyperactivity persists for 24 hours, increasing risks in T2DM patients.

Keywords:
HypoglycaemiaPlateletsType 2 diabetes

More Related Videos

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.7K
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

7.5K

Related Experiment Videos

Last Updated: Feb 10, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
03:17

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice

Published on: March 29, 2024

1.1K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.7K
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

7.5K

Area of Science:

  • Endocrinology
  • Hematology
  • Metabolic Disorders

Background:

  • Strict glycemic control in type 2 diabetes (T2DM) is linked to increased mortality.
  • Understanding the impact of hypoglycemia on platelet function in T2DM is crucial.

Purpose of the Study:

  • To investigate platelet function immediately and 24 hours after induced hypoglycemia in T2DM patients.
  • To compare platelet responses in T2DM patients versus healthy controls.

Main Methods:

  • Induced hypoglycemia using hyperinsulinemic clamps (blood glucose to 2.8 mmol/L for 1 hour).
  • Measured platelet function via whole blood flow cytometry at baseline, euglycemia, hypoglycemia, and 24 hours post-clamp.
  • Recruited 10 T2DM patients and 8 age-matched healthy controls.

Main Results:

  • Platelets from T2DM patients showed reduced sensitivity to prostacyclin (PGI2) post-hypoglycemia.
  • The inhibition of platelet activation by PGI2 was significantly impaired at 24 hours in the T2DM group (fibrinogen binding: 29.5% vs. 50.8%; P-selectin expression: 32% vs. 54.4%).
  • No significant changes in platelet function were observed in healthy controls.

Conclusions:

  • Induced hypoglycemia in T2DM enhances platelet hyperactivity.
  • This hyperactivity is mediated by impaired prostacyclin sensitivity at 24 hours post-hypoglycemia.
  • Findings suggest a potential mechanism linking hypoglycemia to adverse events in T2DM.